Harkins received a B.S degree in Biology (1988) from Texas A&M University. She received her MD degree (1992) from Southwestern University. Following her MD degree, she completed her internship in Delaware and then residency in Internal Medicine at the University of Maryland Medical Systems and a 3 year fellowship in Pulmonary/ Critical Care at University of New Mexico.

Personal Statement

My research interests initially involved clinical studies evaluating the mechanisms for asthma exacerbation and airway inflammation in severe asthmatics. I am co-director of the adult asthma clinic and continue to conduct clinical trials. Much of my clinical time is in the medical intensive care unit and I have an interest in Hantavirus research including longitudinal studies and patient outcomes and evaluating mechanisms of inflammation and further treatment options. With the COVID-19 pandemic, I have now focused on clinical trials for this disease. I also have an active role in Project Echo which is a telehealth program (initially in asthma, then Hantavirus and H1N1,Critical Care for the COVID-19 patient and now Post Covid PC Echo) that provides real time education and case discussions for the community providers.

Areas of Specialty

Critical Care


Diplomate, American Board of Pulmonary Medicine 11/98, exp. 12/2028 Diplomate, American Board of Critical Care 11/99, exp. 12/2029

Achievements & Awards

Top Doc by peers for Critical Care 2022 in The Albuquerque Magazine
Faculty Shero Award, UNM Health Sciences Center-leadership in Covid pandemic, 2020
Reg Strickland Award for outstanding service to Department of Internal Med 2020
Laureate Award NM Chapter, American College of Physicians 2015
FDA Pulmonary-Allergy Drug Advisory Committee: Member 2012-2018
ATS Outstanding Clinician Award, American Thoracic Society, Denver, May 2011




  • English

Research and Scholarship

Bradfute S, Hurwitz I, Yingling AV, Cheng Q, Noonan TP, Sosa NR, Raval JS, Mertz G, Perkins DJ, Harkins MS. SARS-CoV-2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in COVID-19 Patients. J Inf Dis Aug 2020

Goodfellow S, Nofchissey R, Schwalm K, Cook J, Dunnum J, Guo Y,Ye C, Mertz G, Chandran K, Harkins M, Domman D, Dinwiddie D, and Steven Bradfute. Tracing transmission of Sin Nombre virus and discovery of infection in multiple rodent species. J Virology 2021 December doi: 10.1128/JVI.01534-21. Epub 2021 Sep 22

Kalil A, Mehta A, Patterson T, Erdmann N, Gomez C, Jain M, Wolfe C, Ruiz-Palacios G, Kline S, Regalado Pineda J, Luetkemeyer A, Harkins M, et al. for ACTT 3 study group. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med 2021 December S2213-2600(21)00384

Moghimi N, Di Napoli M, Biller J, Siegler J, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, Divani AA. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Current Neurology and Neuroscience Reports (June 2021) 21:44

Simons P, Guo Y, Bondu V, Tigert SL, Harkins M, Goodfellow S, Tompkins C, Chabot-Richards D, Yang XO, Bosc LG , Bradfute S,Daniel A. Lawrence DA and Buranda T. Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease. Viruses August

Haselkorn T, Szefler SJ, Chipps B, Bleecker E, Harkins M, Paknis B, Foreman A, Kianifard F, Ortiz B, Zeiger R. Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II. J of Clin All Immunol in practice Mar 2020

Raissy HH, Kelly HW, Harkins MS, Szefler SJ. Inhaled Corticosteroids in Lung Disease, Part of Modern Pharmacotherapy of Lung Disease Series 2013. Am J Resp Crit Care Med. Vol 187 (8): 798-803 January 2013.doi: 10.1164/rccm.201210-1853PP